VivoSeq
Other

Sorafenib

0

Pipeline Programs↗

1

Active Trials↗

7

Companies Involved↗

Sorafenib is an early-stage landscape with 0 programs across 7 companies. The most active players are Bayer, Yabao Pharmaceutical Group, Xspray Pharma AB.

Intelligence

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

83/100

Attrition Rate

14/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Bayer logo

Bayer

0 programs

PreclinicalY

Yabao Pharmaceutical Group

0 programs

PreclinicalX

Xspray Pharma AB

0 programs

PreclinicalD

Disruptive Pharma

0 programs

PreclinicalA

Association of Urologic Oncology (AUO)

0 programs

PreclinicalAmgen logo

Amgen

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

37

clinical trials

Completed24 · 65%
Unknown status7 · 19%
Terminated4 · 11%
Recruiting1 · 3%
Withdrawn1 · 3%

Clinical Trials

Trial Activity

37 trials

MRD-guided Maintenance Post-HCT: Gilteritini vs Sorafenib
Recruiting·TThe First Affiliated Hospital of Soochow University·Phase 3·NCT07463651·594 enrolled
The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction
Completed·KKorea University Guro Hospital·Phase 4·NCT03212625·288 enrolled
Bioequivalence Study of Sorafenib Tablet and Nexavar
Completed·YYabao Pharmaceutical Group·Phase 1·NCT02599337·36 enrolled
HAIC Plus Sorafenib Versus TACE Plus Sorafenibfor Advanced HCC
Completed·SSun Yat-sen University·Phase 3·NCT02856126·214 enrolled
Sorafenib/Docetaxel Dose Escalation Trial
Completed·Bayer logoBayer·Phase 1·NCT00562523·17 enrolled
Evaluating the Pharmacokinetic Parameters and Relative Bioavailability of Sorafenib (XS005) in Healthy Male Subjects
Completed·XXspray Pharma AB·Phase 1·NCT05967377·15 enrolled
A Study to Assess the Pharmacokinetics of Sorafenib in Mesoporous Magnesium Carbonate (DPH001) Compared to Nexavar® (sorafenib) in Healthy Volunteers
Completed·DDisruptive Pharma·Phase 1·NCT06797427·12 enrolled
Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC
Completed·SSun Yat-sen University·Phase 3·NCT02774187·247 enrolled
BATTLE Program: Sorafenib in Patients With NSCLC
Completed·MM.D. Anderson Cancer Center·Phase 2·NCT00411671·105 enrolled
Sorafenib Chemoembolization Evaluation Controlled Trial
Completed·—·Phase 3·NCT01906216·199 enrolled
Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of Sorafenib and Eribulin in Combination
Completed·Bayer logoBayer·Phase 1·NCT01585870·40 enrolled
The Effect of Sorafenib on Portal Pressure
Completed·YYale University·Phase 2·NCT01714609·10 enrolled
Sorafenib. ICORG 06-41, V4
Completed·CCancer Trials Ireland·Phase 2·NCT01158287·54 enrolled
Sorafenib Long Term Extension Program
Completed·Bayer logoBayer·Phase 3·NCT00625378·206 enrolled
Sorafenib in Elderly mRCC
Completed·Bayer logoBayer·N/A·NCT01728948·60 enrolled
Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)